SLC5A2 and hydrops fetalis: Of utmost importance, the SGLT-2 inhibitors also improve peak VO2 (the most sensitive parameter for exercise capacity and quality of life) in HF patients, both empagliflozin (Santos-Gallego et al., 2021b) and dapagliflozin (Palau et al., 2022).